Resource Logo
New York Times

The AIDS Epidemic Can Be Ended




 

The recent murders of Dwayne Jones, a transgender teenager in Jamaica, and Eric Ohena Lembembe, a gay activist in Cameroon, as well as the global outcry over Russia’s anti-gay legislation have rightly attracted international attention as gross violations of human rights.

While the debate about gay rights in the West has shifted to the rights of same sex couples to marry, these recent events bring back to light the cruel reality that in many countries people who are openly homosexual or suspected of being homosexual are still being thrown in jail for years or even facing death sentences. It beggars belief that in sub-Saharan Africa homosexuality remains illegal in 38 countries.

It is crucial that pressure be stepped up on governments that, through punitive laws, continue to make the daily lives of homosexuals a nightmare. But even greater pressure can be exerted if we acknowledge that this deprivation of human rights goes beyond mere civil liberties: It is bad public health.

Three decades of experience in responding to the H.I.V./AIDS epidemic has provided indisputable evidence that depriving those groups most at risk of H.I.V. infection of their human rights drives them underground. The impact is twofold: Not only do sex workers, men who have sex with men, drug users and transgender people live in daily fear of reprisals, but precisely because of that they are considerably less likely to access basic health services such as condoms to protect themselves from infection. Education campaigns that reach the general population are unlikely to reach these populations, and it is no surprise that in many parts of the world H.I.V. prevalence among sex workers, men who have sex with men, transgender people and sex workers is much higher than in other populations.

In the early days of the H.I.V./AIDS epidemic, it was soon evident that the virus did not discriminate but that governments and people sometimes did. Today stigma and discrimination still fuel the epidemic — and we need look no further than Russia to see how repression and inaction have worsened one of the fastest-growing H.I.V. epidemics in the world.

A decade ago estimates of the number of people in Russia living with H.I.V. ranged from 100,000 to twice that, most of whom were sickened by intravenous drug use. Today the figure stands at an alarming one million. Much of the blame lies with the public authorities’ refusal to support the provision of opioid substitution therapy, like methadone, or of clean needles.

Intravenous drug users are subject to widespread discrimination in Russian society, and the government’s notorious “treatment” centers have drawn harsh condemnation for their human rights abuses over the years.

It comes as no surprise that, in a country as historically distrustful of homosexuality and “Western” campaigns to give homosexuals increased rights, the rate of H.I.V. prevalence among men who have sex with men, especially younger men, is considerably higher than the general population.

The renewed hard-line approach by the government only adds to the climate of fear for L.G.B.T. organizations — and will do little to bring down the rate of new infections among gay men.

Much the same can be said of many of those 38 sub-Saharan African countries where homosexuality is still illegal. Their rates of H.I.V. among men who have sex with men are sketchy because of the fears of many men to be identified as having sex with other men.

The potential for H.I.V. transmission among gay men in Russia as well as sub-Saharan Africa is very clear. At the same time, we know what steps can be taken that work to stem this tide.

In the 1980s the implementation of needle-exchange and methadone programs was instrumental in preventing a spiraling epidemic among people who inject drugs. Today Western Europe, the United States and many other countries have close to zero H.I.V. prevalence among intravenous drug users.

In countries like Portugal and the Czech Republic, the decriminalization of small amounts of drugs for personal use during the 1990s was a major factor behind the drop in H.I.V. infection rates. Conferring on drug users the right to dignified medical services and referring them to treatment centers as opposed to locking them up have produced a revolution in public health policy in those countries.

Engaging the homosexual community in this battle brings broad public health benefits, and Australia is a case in point. Only 35 years ago participants at the first Mardi Gras rally in Sydney were arrested and beaten; discrimination and violence against homosexuals by the police and the wider community were common. While the violence in 1978 certainly galvanized the gay community, it was the onset of H.I.V./AIDS a few years later that led its members to become a powerful voice in the development of Australia’s much-lauded bipartisan approach to fighting the disease. Containment of the H.I.V./AIDS epidemic in Australia was a public health milestone — achieved through legislation that implicitly recognized the human rights of homosexuals.

In less than two years the United Nations’ Millennium Development Goals will come due. In the case of H.I.V./AIDS, the goals are to get preventative treatment to 15 million people and to reverse the epidemic. But unless gay people and other affected groups enjoy the same legal human rights and protections as their fellow citizens, then neither of those targets seems plausible.

We have at our disposal the scientific knowledge to bring the AIDS epidemic to an end. But we cannot apply that science worldwide because so many people at high risk of infection fear recrimination and are reluctant to seek help from the organizations that can help them.

Unfortunately political leaders in many parts of the world are the true drivers of the stigma against gays. But it is those very leaders who have a historic opportunity not only to end such discrimination but to make a major dent in one of the world’s most lethal pandemics in their own backyards.

Bertrand Audoin is the executive director of the International AIDS Society.



 


Copyright © 2013 -New York Times, Publisher. All rights reserved to New York Times company. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

Information in this article was accurate in August 20, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.